Literature DB >> 6184586

ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis.

P A Berg, R Klein, J Lindenborn-Fotinos, W Klöppel.   

Abstract

Serum samples from 94 patients with primary biliary cirrhosis (PBC) and 17 patients with chronic cholestatic hepatitis (CCH) were tested in the fluorometric immunoassay (FIAX) against the nonorgan-specific ATPase-associated antigen (M2) and against submitochondrial from beef heart and rat liver, to evaluate the specificity and sensitivity of the M2 antigen for the diagnosis of PBC. As controls serum samples from 42 patients with other antimitochondrial antibody (AMA) specificity (against M1, M3, M5, and M6) as well as samples from 417 patients with various other hepatic and non-hepatic disorders were used. Serum samples from 91 of the 94 PBC patients (97%) and all 17 with CCH reacted with the M2 antigen. However, when SMP from rat liver and beef heart were tested in parallel in the FIAX, AMA could be detected in all PBC serum samples. None of the 42 patients with different types of AMA had reactions with the M2 antigen but all had reactions with SMP from rat-liver or beef-heart mitochondria or both. Among the other 417 patients with hepatic and non-hepatic disorders only 4(1%), all with collagen diseases, had anti-M2 antibodies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184586     DOI: 10.1016/s0140-6736(82)91327-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

1.  Cardiolipin-fluorescent (M1) antimitochondrial antibody and cholestatic hepatitis in secondary syphilis.

Authors:  G M Comer; S Mukherjee; R K Sachdev; D J Clain
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

2.  Anti-mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis.

Authors:  L Zhang; A P Weetman; D R Jayne; I Turner; S J Yeaman; M F Bassendine; D B Oliveira
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

Review 3.  Primary biliary cirrhosis: nature of autoantigens.

Authors:  M F Bassendine; S J Yeaman
Journal:  Springer Semin Immunopathol       Date:  1990

Review 4.  Recent developments in primary biliary cirrhosis: etiology and treatment.

Authors:  U Hopf; R Stemerowicz
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

5.  Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance.

Authors:  B Preuss; C Berg; F Altenberend; M Gregor; S Stevanovic; R Klein
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

6.  Two different types of antimitochondrial antibodies (anti-M2 and anti-M4) may not differentiate primary biliary cirrhosis (PBC) with prominent piecemeal necrosis from classical PBC.

Authors:  T Okuno; M Shindo; M Matsumoto; K Arai; M Takeda; M Iwai; T Nakashima; T Takino
Journal:  Gastroenterol Jpn       Date:  1989-02

7.  Primary biliary cirrhosis: further biochemical and immunological characterization of mitochondrial antigens.

Authors:  I Mendel-Hartvig; B D Nelson; L Lööf; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

8.  Specificity of antinuclear antibodies in primary biliary cirrhosis.

Authors:  M J Chou; S L Lee; T Y Chen; G J Tsay
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

9.  Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9.

Authors:  P A Berg; R Klein
Journal:  Klin Wochenschr       Date:  1986-10-01

10.  Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis.

Authors:  R Klein; M Wiebel; S Engelhart; P A Berg
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.